Abstract:Cytochrome P450 2D6 (CYP2D6) is an enzyme that is involved in the metabolism of roughly 25% of all marketed drugs and therefore belongs to the most important enzymes in drug metabolism. CYP2D6 features a high degree of genetic polymorphism that can significantly affect the metabolic activity of an individual. In extreme cases, structural changes at the level of single amino acids can either increase its enzymatic activity abolishing the drug therapeutic effect or completely disable the enzyme and elevate drug plasma level potentially leading to adverse effects. In this study, starting from the crystal structure, we built a full-length membrane-anchored all-atom model of the wild-type CYP2D6 as well as five of its variants differing in the enzymatic activity. We validated our models with available experimental data and compared their structural properties with molecular dynamics simulations. The main focus of this study was to identify differences that could mechanistically explain the altered activity of the variants and improve our understanding of their functioning. We observed differences in the opening frequencies and minimal diameters of tunnels that connect the buried active site to the surrounding solvent environment. The variants CYP2D6*4 and CYP2D6*10 associated with missing or decreased activity showed less frequent opening of the tunnels compared to the wild-type. Both CYP2D6*10 and CYP2D6*17 showed a deprivation of an important ligand tunnel suggesting a feasible reason for their altered substrate specificity. Next, the altered fold at the N-terminal anchor region and the decreased active site volume caused by the amino acid mutations of the CYP2D6*4 variant offer an explanation for the absence of its metabolic activity. The mutations in CYP2D6*53 contributed to a significant enlargement of an important ligand tunnel and an extension of the active site cavity. This could explain the altered metabolic profile as well as the enhanced metabolic rates of this particular variant supporting its designation as a possible cause for the ultrarapid metabolizer phenotype. We believe these novel structural insights could advance the fields of personalized medicine and enzyme engineering. Furthermore, they could aid in guiding laboratory as well as computational experiments in the future.

Impact of peripheral mutations on the access channels of human cytochrome P450 1A2.

Long-Range Effects of a Peripheral Mutation on the Enzymatic Activity of Cytochrome P450 1A2.

How Mutations Affecting the Ligand-Receptor Interactions: A Combined Md and Qm/Mm Calculation on Cyp2e1 and Its Two Mutants

Mutations of Charged Amino Acids at the Cytoplasmic End of Transmembrane Helix 2 Affect Transport Activity of the Budding Yeast Multidrug Resistance Protein Pdr5p.

A Theoretical Study on the Mechanism of a Superficial Mutation Inhibiting the Enzymatic Activity of CYP1A2

How do mutations affect the structural characteristics and substrate binding of CYP21A2? An investigation by molecular dynamics simulations.

Molecular Dynamics Simulations Reveal Structural Differences among Allelic Variants of Membrane-Anchored Cytochrome P450 2D6

Exploring the structure characteristics and major channels of cytochrome P450 2A6, 2A13, and 2E1 with pilocarpine.

Reduced Catalytic Activity of P450 2A6 Mutants with Coumarin: A Computational Investigation

Insights into the structure, function, and regulation of human cytochrome P450 1A2.

Influence Of Various Polymorphic Variants Of Cytochrome P450 Oxidoreductase (Por) On Drug Metabolic Activity Of Cyp3a4 And Cyp2b6

Molecular dynamic investigations of the mutational effects on structural characteristics and tunnel geometry in CYP17A1.

Structural basis for the mutation-induced dysfunction of human CYP2J2: a computational study.

Metabolism and Mechanism of Human Cytochrome P450 Enzyme 1A2

Mutagenesis and Molecular Dynamics Suggest Structural and Functional Roles for Residues in the N-terminal Portion of the Cytochrome P450 2B1 I Helix

Interactions of CYP2C9 with Different Substrates and Its Implications for Metabolic Mechanism

Mechanism of the decrease in catalytic activity of human cytochrome P450 2C9 polymorphic variants investigated by computational analysis.

MD simulations and QM/MM calculations show that single-site mutations of cytochrome P450 BM3 alter the active site's complexity and the chemoselectivity of oxidation without changing the active species.

Molecular dynamics simulations of CYP2E1.

Insights into the Substrate Specificity, Inhibitors, Regulation, and Polymorphisms and the Clinical Impact of Human Cytochrome P450 1A2

Assessing the Role of Residue Phe108 of Cytochrome P450 3A4 in Allosteric Effects of Midazolam Metabolism.